SecBot SecBot
COURT-RULING ·Filed Apr 16, 2026

DGX

QUEST DIAGNOSTICS INC
NEUTRAL
Impact 2/10
Horizonmonths Processed4mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

The ruling is procedural and does not change the outlook for DGX. Monitor the MDL for substantive rulings on liability and potential settlement discussions.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$195.02
T+0 close · Apr 17, 2026 · via day close
Latest settled
+3.46%
T+60 · $201.77
Vs SPY
−2.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 17 $195.02entry
  2. T+1 · 7mo ago +0.66%α +0.86% · $196.31
  3. T+5 · 7mo ago +0.64%α +0.11% · $196.27
  4. T+20 · 6mo ago −4.31%α −8.40% · $186.61
  5. T+60 · 4mo ago +3.46%α −2.83% · $201.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The court denied plaintiff's motion to remand a data breach class action against Quest Diagnostics to California state court, keeping the case in federal multidistrict litigation (MDL 2904). This procedural ruling does not affect the merits of the case and has no immediate financial impact.

Court Ruling Details

Ruling Date
Apr 16, 2026
Court
District Court, D. New Jersey
Court Level
District
Judge
Jamel K. Semper
Case Type
other
Ruling Type
procedural
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Court denied motion to remand class action related to AMCA data breach
  • Case will remain in federal MDL proceedings
  • No damages awarded or liability determined

Financial Impact

No financial impact from this procedural ruling

Risk Factors

  • Potential class certification could increase financial exposure
  • Data breach litigation could lead to regulatory penalties or reputational harm

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
54% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-b0d3lor4-DGX

Track record

24 reports on DGX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
  3. Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
  5. Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  7. Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
  8. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  9. Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jul 3, 2026